antithrombotic agents
Management of antithrombotic agents in patients undergoing flexible bronchoscopy
... A bronchoscopist is often involved in the management of antithrombotic agents (ATAs) in the peri-procedural period. Patients are prescribed these medications for a variety of indications, and the decision ...
16
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents
... available antithrombotic agents inhibit either platelet aggregation or fibrin generation, inhibition of secreted PDI blocks the earliest stages of thrombus formation, suppressing both ...
11
Colorectal endoscopic mucosal resection with submucosal injection of epinephrine versus hypertonic saline in patients taking antithrombotic agents: propensity-score-matching analysis
... Endoscopic polypectomy for colon lesions effectively reduces the risk of colorectal cancer [1, 2)]. Endoscopic mucosal resection (EMR), which involves the injection of fluid to expand the submucosal space, simplifies ...
9
Mortality among head trauma patients taking preinjury antithrombotic agents: a retrospective cohort analysis from a Level 1 trauma centre
... Results: Of the 418 patients admitted with a diagnosis of head trauma, 137 (32.8 %) used pre-injury antithrombotic agents (53 warfarin, 80 platelet inhibitors, and 4 both). Seventy patients died (16.7 %); ...
8
Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
... of antithrombotic agents during endoscopic procedures was recommended because the emphasis was on the prevention of GI ...such agents have been widely reported ...of antithrombotic ...
9
Emerging antithrombotic agents for thromboprophylaxis, clinical potential and patient considerations
... Abstract: Patients undergoing major orthopedic surgery, total hip arthroplasty (THA) and total knee arthroplasty (TKA) are at high risk of venous thromboembolism, manifesting as deep vein thrombosis or pulmonary ...
8
Dabigatran and other oral antithrombotic agents for the prevention of stroke in patients with atrial fibrillation
... Several new oral anticoagulants have been recently developed. The results of RE-LY indicate that dabigatran is a safe and efficacious alternative to warfarin for the prevention of stroke and systemic embolism in patients ...
11
Antithrombotic therapy in patients with atrial fibrillation : the Tasmanian experience
... Dabigatran, rivaroxaban, apixaban and edoxaban have been compared to warfarin in patients with AF in four pivotal clinical trials.(66, 71, 74, 76) The data from these trials indicated that, generally, the DOACs are at ...
200
Poor outcomes associated with antithrombotic undertreatment in patients with atrial fibrillation attending Gondar University Hospital: a retrospective cohort study
... the risk of stroke in patients with NVAF and classify patients into high, moderate, and low risk categories. This score was used to determine the appropriateness of antithrombotic agents. However, as ...
10
PLANT AS ANTICOGULANT/ANTITHROMBOTIC AGENT
... countries. Antithrombotic agents are used to prevent thrombosis and thrombolytic agents are used to dissolve the already formed clots in the blood vessels however, these drugs have certain ...
13
Antithrombotic Therapy in Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Network Meta-Analysis
... Among antithrombotic agents, aspirin monotherapy has been recommended as the mainstay of prevention of saphenous vein graft failure (SVGF) in patients undergoing coronary artery bypass graft (CABG) surgery, ...
157
PubMedCentral-PMC5213813.pdf
... using antithrombotic agents is complicated by an excessive risk of bleeding in ESRD patients ...of antithrombotic agents in HD patients ...
14
Does antithrombotic therapy improve survival with colorectal cancer?
... used antithrombotic agents for >3 months continuously prior to the colorectal cancer diagnosis, and non-users (the control group), those who did not use antithrom- botic ...anticoagulant agents ...
8
Profile of acute upper gastro intestinal bleed: a referral hospital-based study in sub Himalayan region
... multiple antithrombotic agents and novel anticoagulants, the present study was designed with the aim to assess the clinical profile of UGIB presenting to the Department of Medicine in sub Himalayan ...
5
Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two phase study
... use antithrombotic agents in patients with atrial fibrillation at risk of stroke involves a choice between aspirin or warfarin ...of antithrombotic therapy is sensitive to prefer- ences for the ...
13
Triple antithrombotic therapy for atrial fibrillation and coronary stents
... and Antithrombotic Regimen-testing of a 6-week versus a 6-month Clopidogrel Treatment Regimen in Patients with Concomitant Aspirin and Oral Anticoagulant Therapy Following Drug-eluting Stenting; ISTH—International ...
7
Antithrombotic Effects of Different Strains of Lactic Acid Bacteria
... the antithrombotic properties of different strains of orally available antithrombotic lactic acid bacteria ...dures: Antithrombotic activity, antiplatelet reactivity and/or thrombolytic activity, ...
12
Protective Effects of Nobiletin on Hypertension and Cerebral Thrombosis in Stroke Prone Spontaneously Hypertensive Rats (SHRSP)
... and antithrombotic effects of nobiletin may be related to an increase in bioavailable NO, possibly mediated by the scavenging of reactive oxygen species ...
8
The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?
... The underlying inflammation of atheromata in acute cor- onary syndromes could be the basis of failure of intensive antithrombotic therapy [88]. COX-2 inhibition may decrease athero-inflammation, reducing monocyte ...
8
Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study
... to antithrombotic treatments, outpatient services such as postoperative visit, ultrasound, magnetic resonance, Rx, ecocolordoppler, D-dimer, complete blood count, fibrinogen, prothrombin time, partial ...
7